Misplaced Pages

This is an old revision of this page, as edited by 209.221.240.193 (talk) at 19:10, 15 October 2019. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Oswaldo Cruz Foundation" – news · newspapers · books · scholar · JSTOR (January 2009) (Learn how and when to remove this message)

22°52′29.57″S 43°14′43.58″W / 22.8748806°S 43.2454389°W / -22.8748806; -43.2454389

Oswaldo Cruz Foundation
Fundação Oswaldo Cruz

Founded	25 May 1900
Founder	Oswaldo Cruz
Location	Rio de Janeiro, RJ, Brazil
Official languages	Portuguese
Key people	Nísia Trindade Lima (President)
Website	Fiocruz

The Oswaldo Cruz Foundation (Portuguese Fundação Oswaldo Cruz, also known as FIOCRUZ) is a scientific institution for research and development in biological sciences located in Rio de Janeiro, Brazil, it is considered one of the world's main public health research institutions. It was founded by Dr. Oswaldo Cruz, a noted physician and epidemiologist.

The organization started in 1898 as the Federal SeroTherapy Institute with the objective of developing serum and vaccines against the bubonic plague. It was located outside of Rio de Janeiro. The institute’s activities, however, changed from simple production into research and experimental medicine, especially after Oswaldo Cruz assumed its leadership in 1902. From there on, the institute became the base for memorable sanitation campaigns in an age of outbreaks and epidemics of the bubonic plague, yellow fever, and smallpox. The Institute, however, was not confined to Rio de Janeiro and, on the contrary, collaborated in the occupation of the country’s interior through scientific expeditions, aiding in the development of the country.

When Oswaldo Cruz died, in 1917, the Institute, which by then already bore his name, was nationally consolidated through important scientific achievements, such as Carlos Chagas’ description of the complete cycle of the American trypanosomiasis including the clinical pattern of the disease. On 16 January 2007, the Institute announced that it had developed a gel from algae which it is hoped will reduce HIV transmission to women.

Today the institution has a broad range of responsibilities related to the health and wellbeing of the Brazilian population. This includes hospital and ambulatory care; health-related research; development of vaccines, drugs, reagents, and diagnostic kits; training of public health and health workers; and providing information and communications related to health, science, and technology. The Fiocruz workforce members are over 7,500. Fiocruz includes several fixed facilities in Rio de Janeiro and other locations; however, it contributes to improving health throughout the country, through its support to the Sistema Único de Saúde (Unified Health System, the Brazilian public health system), its proposals on public health policy-making, its research activities, its scientific expeditions, and the reach of its health services and products.

Fiocruz is one of the founding members of the International Association of National Public Health Institutes, a membership organization of national public health institutes.

See also

• Fiocruz Genome Comparison Project
• Museum of Life
• Memórias do Instituto Oswaldo Cruz, its official medical journal

References

1. ^ "History of Fiocruz Minas – Centro de Pesquisas René Rachou". Retrieved 3 February 2016.
2. "Algae gel to combat HIV infection". BBC News. 16 January 2007. Retrieved 5 January 2010.
3. "Hisyory". IANPHI. Archived from the original on April 28, 2013. Retrieved August 4, 2014.

External links

• Official website

• Medical and health organisations based in Brazil
• Medical research institutes
• Public health organizations
• Organisations based in Rio de Janeiro (city)